672285-91-5 Usage
Uses
Used in Pharmaceutical Industry:
1-Piperazineaceticacid,4-ethyl-(9CI) is used as a building block for the synthesis of various biologically active compounds due to its versatile chemical structure and potential therapeutic properties.
Used in Anticonvulsant Applications:
In the field of neurology, 1-Piperazineaceticacid,4-ethyl-(9CI) is used as an anticonvulsant agent, potentially helping to prevent or reduce the severity of seizures by modulating neuronal excitability.
Used in Anxiolytic Applications:
For mental health applications, 1-Piperazineaceticacid,4-ethyl-(9CI) is used as an anxiolytic agent, which may help in alleviating symptoms of anxiety by influencing neurotransmitter levels and receptor activities in the brain.
Used in Analgesic Applications:
In pain management, 1-Piperazineaceticacid,4-ethyl-(9CI) is used as an analgesic agent, potentially providing relief from pain by interacting with pain receptors or pathways in the nervous system.
Used in Anti-inflammatory Applications:
In the treatment of inflammatory conditions, 1-Piperazineaceticacid,4-ethyl-(9CI) is used as an anti-inflammatory agent, which may help reduce inflammation by inhibiting the production of inflammatory mediators or modulating immune responses.
Check Digit Verification of cas no
The CAS Registry Mumber 672285-91-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,2,2,8 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 672285-91:
(8*6)+(7*7)+(6*2)+(5*2)+(4*8)+(3*5)+(2*9)+(1*1)=185
185 % 10 = 5
So 672285-91-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H16N2O2/c1-2-9-3-5-10(6-4-9)7-8(11)12/h2-7H2,1H3,(H,11,12)
672285-91-5Relevant academic research and scientific papers
PROTEIN KINASE INHIBITORS
-
, (2015/02/18)
A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
PROTEIN KINASE INHIBITORS
-
, (2013/04/25)
A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
3-BENZOFURANYL-INDOL-2-ONE DERIVATIVES SUBSTITUTED AT THE 3 POSITION, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF
-
, (2012/03/08)
The invention relates to 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position and of the formula (I) where R1, R2, R3, R4, R5 and n are such as defined in claim 1, to a method for preparing same, and to the therapeutic use of said compound
INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
-
Page/Page column 11, (2010/08/22)
The present invention relates to 3-disubstituted indol-2-one derivatives, to their preparation and to their therapeutic application.
NK1 and NK3 antagonists
-
Page/Page column 28, (2010/02/14)
The invention is to a compound exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising same and a method of treatment for neurokinin-mediated conditions.
